HEPATIC EXPRESSION OF A RECEPTOR-BINDING-DEFECTIVE HUMAN APOLIPOPROTEIN-E VARIANT CREATES A MODEL OF TYPE-III HYPERLIPOPROTEINEMIA IN TRANSGENIC MICE

被引：0
|
作者：
FAZIO, S [1 ]
SIMONET, WS [1 ]
RALL, SC [1 ]
机构：
[1] UNIV CALIF SAN FRANCISCO,GLADSTONE INST CARDIOVASC DIS,SAN FRANCISCO,CA 94143
来源：
CIRCULATION | 1992年 / 86卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：278 / 278
页数：1
相关论文
共 50 条
  • [41] POLYMORPHISM OF APOLIPOPROTEIN-E .1. METHODOLOGICAL ASPECTS AND DIAGNOSIS OF HYPERLIPOPROTEINEMIA TYPE-III WITHOUT ULTRA-CENTRIFUGATION
    UTERMANN, G
    ALBRECHT, G
    STEINMETZ, A
    CLINICAL GENETICS, 1978, 14 (06) : 351 - 358
  • [42] GRADIENT ULTRA-CENTRIFUGATION AND APOLIPOPROTEIN-E ISOELECTRIC-FOCUSING IN A FAMILY WITH COEXISTENT HYPERLIPOPROTEINEMIA TYPE-III AND IIA
    LEUVEN, JAG
    HAVEKES, L
    VANPELT, W
    EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 1982, 12 (02) : 13 - 13
  • [43] Genetic factors precipitating type III hyperlipoproteinemia in hypolipidemic transgenic mice expressing human apolipoprotein E2
    Huang, Y
    Rall, SC
    Mahley, RW
    ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 1997, 17 (11) : 2817 - 2824
  • [44] HEPATIC AND RENAL EXPRESSION OF RAT APOLIPOPROTEIN-E UNDER CONTROL OF THE METALLOTHIONEIN PROMOTOR IN TRANSGENIC MICE
    SHIMANO, H
    YAMADA, N
    SHIMADA, M
    OHSAWA, N
    FUKAZAWA, C
    YAZAKI, Y
    TAKAKU, F
    KATSUKI, M
    BIOCHIMICA ET BIOPHYSICA ACTA, 1991, 1090 (01) : 91 - 94
  • [45] OPPOSING EFFECTS OF HUMAN APOLIPOPROTEIN-E AND APOLIPOPROTEIN-C-III IN LIPOPROTEIN REMNANT CLEARANCE IN TRANSGENIC MICE
    DESILVA, HV
    LAUER, SJ
    WANG, J
    NEWHOUSE, Y
    SHINTO, L
    MAHLEY, RW
    WEISGRABER, KH
    TAYLOR, JM
    CIRCULATION, 1992, 86 (04) : 471 - 471
  • [46] APOLIPOPROTEIN E-1-HARRISBURG(H) - A POINT MUTATION RESULTING IN DOMINANT EXPRESSION OF TYPE-III HYPERLIPOPROTEINEMIA
    MANN, AW
    GREGG, RE
    RONAN, R
    THOMAS, F
    ZECH, LA
    BREWER, HB
    ARTERIOSCLEROSIS, 1988, 8 (05): : A612 - A612
  • [47] EXPRESSION OF TYPE-III HYPERLIPOPROTEINEMIA IN A SUBJECT WITH SECONDARY HYPOTHYROIDISM BEARING THE APOLIPOPROTEIN E2/2 PHENOTYPE
    FEUSSNER, G
    ZIEGLER, R
    JOURNAL OF INTERNAL MEDICINE, 1991, 230 (02) : 183 - 186
  • [48] Transgenic mice with macrophage specific expression of human scavenger receptor A and human apolipoprotein E
    Tennert, C
    Teupser, D
    Müller, M
    Wilfert, W
    Döring, C
    Jeromin, F
    Thiery, J
    ATHEROSCLEROSIS SUPPLEMENTS, 2003, 4 (02) : 152 - 152
  • [49] ROLE OF APOLIPOPROTEIN-E IN THE LIPOLYTIC CONVERSION OF BETA-VERY- LOW-DENSITY LIPOPROTEINS TO LOW-DENSITY LIPOPROTEINS IN TYPE-III HYPERLIPOPROTEINEMIA
    EHNHOLM, C
    MAHLEY, RW
    CHAPPELL, DA
    WEISGRABER, KH
    LUDWIG, E
    WITZTUM, JL
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA-BIOLOGICAL SCIENCES, 1984, 81 (17): : 5566 - 5570
  • [50] MULTIPLE TISSUE-SPECIFIC REGULATORY ELEMENTS CONTROL THE EXPRESSION OF THE HUMAN APOLIPOPROTEIN-E GENE IN TRANSGENIC MICE
    SIMONET, WS
    BUCAY, N
    LAUER, SJ
    DESILVA, HV
    PITAS, RE
    WEISGRABER, KH
    TAYLOR, JM
    CIRCULATION, 1990, 82 (04) : 433 - 433
12345